Alerts will be sent to your verified email
Verify Email
TATVA
|
Tatva Chintan Pharma
|
Paushak
|
Vishnu Chemicals
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.37 % | 13.05 % | 21.61 % |
|
5yr Avg Net Profit Margin
|
14.46 % | 25.34 % | 7.92 % |
|
Price to Book
|
3.33 | 4.04 | 3.57 |
|
P/E
|
343.67 | 36.79 | 25.77 |
|
5yr Avg Cash Conversion Cycle
|
136.22 Days | -20.97 Days | 3.08 Days |
|
5yr Average Interest Coverage Ratio
|
12.28 | 597.4 | 4.76 |
|
5yr Avg ROCE
|
21.27 % | 15.36 % | 21.95 % |
|
5yr Avg Operating Profit Margin
|
19.99 % | 33.38 % | 15.1 % |
|
5 yr average Debt to Equity
|
0.38 | 0.01 | 0.95 |
|
5yr CAGR Net Profit
|
-4.29 % | 5.77 % | 29.71 % |
|
5yr Average Return on Assets
|
11.17 % | 10.91 % | 8.35 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.02 % | 67.13 % | 69.21 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-7.15 % | 0.16 % | -5.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-5.27 % | 0.0 | 4.53 % |
|
Tatva Chintan Pharma
|
Paushak
|
Vishnu Chemicals
|
|---|